MSN Pharmaceuticals, Inc. v. Novartis Pharmaceuticals Corp.
Petition for certiorari denied on December 15, 2025
Issue: Whether, in a patent-infringement suit, a court may consider after-arising technology to hold that the patent is invalid under 35 U.S.C. § 112(a) of the Patent Act.